4
Changes in Ownership
Amphastar Pharmaceuticals, Inc. Filed Acc 0001104659-19-022341
President and General Counsel sold 9,478 shares at $20.67 ($195,879)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Shandell Jason B. President and General Counsel | 2019-04-16 | Sale | −9,478 | $20.67 | $195,879 | 159,947 | D |
| Open-market sales · 9,478 sh · avg $20.67 · $195,879 | |||||||
Loading xslF345X03/a4.xml…